COVID-19 vaccine Archives | Page 12 of 19 | Be Korea-savvy
Vaccine Distribution on Roll for 1st Shots on Friday

Vaccine Distribution on Roll for 1st Shots on Friday

SEOUL, Feb. 25 (Korea Bizwire) — Trucks packed with the first of some 1.57 million doses of coronavirus vaccines were distributed across South Korea on Thursday as long-term care hospitals and public health centers rushed to prepare for the country’s ambitious vaccination program. The nationwide distribution of the AstraZeneca vaccine for some 785,000 people, mostly [...]

1st Batch of COVID-19 Vaccines Shipped in S. Korea Ahead of Public Inoculation Program

1st Batch of COVID-19 Vaccines Shipped in S. Korea Ahead of Public Inoculation Program

SEOUL, Feb. 24 (Korea Bizwire) – Shipments of the first batch of COVID-19 vaccines for South Koreans began Wednesday as health authorities gear up to launch a public inoculation program later this week. The inaugural shipments of vaccines developed by British-Swedish pharmaceutical giant AstraZeneca were made at a drug manufacturing plant of SK Bioscience Co. [...]

S. Korea to Begin Inoculations This Week, Herd Immunity by Nov. in Question

S. Korea to Begin Inoculations This Week, Herd Immunity by Nov. in Question

SEOUL, Feb. 23 (Korea Bizwire) — South Korea will begin its first inoculations against the novel coronavirus later this week, health authorities said Tuesday, adding it might not be able to achieve herd immunity by November. The Korea Disease Control and Prevention Agency (KDCA) said it will launch the free inoculation program with British-Swedish pharmaceutical [...]

Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico

Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico

GAITHERSBURG, Md., Feb. 22 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in the United States and Mexico to evaluate the efficacy, safety and immunogenicity of the company’s COVID-19 vaccine. Novavax has previously reported positive interim [...]

Less than Half of S. Koreans Willing to Receive COVID-19 Vaccine Shots Immediately

Less than Half of S. Koreans Willing to Receive COVID-19 Vaccine Shots Immediately

SEOUL, Feb. 22 (Korea Bizwire) — Less than half of South Koreans are willing to receive COVID-19 vaccine shots immediately, without waiting for further reports on those vaccines’ effects, an opinion poll showed Monday. In the survey conducted on 1,020 people aged 18 or over by the Korea Society Opinion Institute from last Friday to [...]

Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine

Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine

GAITHERSBURG, Md., Feb. 18 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to provide 1.1 billion cumulative doses of NVX-CoV2373, Novavax’ recombinant protein-based COVID-19 vaccine candidate, for the COVAX Facility. The vaccine doses [...]